News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Christoph Westphal Resigns as Sirtris Pharmaceuticals (SIRT) CEO, Takes Over GlaxoSmithKline (GSK)'s SR One Venture Arm



4/22/2010 7:12:58 AM

Xconomy -- Christoph Westphal is leaving his CEO job at Sirtris Pharmaceuticals, the Cambridge, MA-based developer of drugs that target genes linked to the aging process, to get back into the venture capital game, according to an e-mail Westphal sent to friends and colleagues as well as Xconomy.

Read at Xconomy
Read at Mass High Tech


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES